FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thierry Poynard

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Livers

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Marika Rudler; Thierry Poynard; Dominique Thabut
Liver stiffness, platelets, and spleen size is reliable in nondecompensated cirrhotic patients.
Thierry Poynard; Larysa Fedchuk; Pascal Lebray; Elena Luckina; Mona Munteanu; Yen Ngo; Raluca Pais; Hugo Perazzo; Luca Royer; Marika Rudler; Florence Sattonnet; Dominique Thabut; Vlad Ratziu
Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard.
Thierry Poynard; Eugene R Schiff; Thomas Berg; Navdeep Boparai; Clifford A Brass; Jordi Bruix; Margaret Burroughs; Flair Carrilho; Moises Diago; Louis H Griffel; Ruiyun Jiang; Andre C Lyra; Ricardo Moreno-Otero; Janice K Albrecht
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thierry Poynard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marika Rudler; Thierry Poynard; Dominique Thabut
Liver stiffness, platelets, and spleen size is reliable in nondecompensated cirrhotic patients.
Gastroenterology 2013;144(5):1150.
2013: Thierry Poynard; Larysa Fedchuk; Pascal Lebray; Elena Luckina; Mona Munteanu; Yen Ngo; Raluca Pais; Hugo Perazzo; Luca Royer; Marika Rudler; Florence Sattonnet; Dominique Thabut; Vlad Ratziu
Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard.
Journal of hepatology 2013;58(5):928-35.
2013: Thierry Poynard; Eugene R Schiff; Thomas Berg; Navdeep Boparai; Clifford A Brass; Jordi Bruix; Margaret Burroughs; Flair Carrilho; Moises Diago; Louis H Griffel; Ruiyun Jiang; Andre C Lyra; Ricardo Moreno-Otero; Janice K Albrecht
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: a randomized study.
Journal of hepatology 2013;58(3):452-9.
2013: Patrice Couzigou; Juliette Foucher; Vincent Leroy; Patrick Marcellin; Sophie Pérusat; Thierry Poynard; Pascale Trimoulet; Marc Bourlière; Jean-Pierre Bronowicki; Geneviève Chêne
Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).
Journal of gastroenterology and hepatology 2013;28(2):329-34.
2013: Marika Rudler; Jean-Christophe Vaillant; Philippe Cluzel; Adeline Martin-Dupray; Julien Massard; Fabrice Menegaux; Séverine Noullet; Thierry Poynard; Dominique Thabut
Optimal nonsurgical management of peptic ulcer bleeding, including arterial embolization is associated with a mortality below 1%.
Clinics and research in hepatology and gastroenterology 2013;37(1):64-71.
2012: Nicole Forestier; Joerg Albert; Jörg Bojunga; Georg Dultz; Antonia Gaus; Ludmila Gerber; Eva Herrmann; Thierry Poynard; Christoph Sarrazin; Maximilian-David Schneider; Stefan Zeuzem; Mireen Friedrich-Rust
Acoustic radiation force impulse imaging for evaluation of antiviral treatment response in chronic hepatitis C.
Journal of gastrointestinal and liver diseases : JGLD 2012;21(4):367-73.
2012: Benjamin Terrier; Guillaume Geri; Frédéric Jehan; Mona Munteanu; Thierry Poynard; David Saadoun; Damien Sène; Jean-Claude Souberbielle; Patrice Cacoub
Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection.
Rheumatology (Oxford, England) 2012;51(11):2083-90.
2012: Thierry Poynard; Vlad Ratziu; Carol Stanciu; Anca Trifan; Jean-Christophe Vaillant; Julien Vergniol; Jean-Pierre Zarski; Frédéric Charlotte; Victor de Ledinghen; Julie France; Gilles Lenaour; Mona Munteanu
Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.
Clinics and research in hepatology and gastroenterology 2012;36(5):455-63.
2012: F Fred Poordad; Thierry Poynard; Heather L Sings; Vilma Sniukiene; Mark S Sulkowski; Stefan Zeuzem; Janice K Albrecht; Bruce R Bacon; Navdeep Boparai; Clifford A Brass; Jean-Pierre Bronowicki; Margaret H Burroughs; Stuart Gordon; Venkata S Goteti; Ira M Jacobson; Cliona Molony; Timothy R Morgan; Lisa Pedicone
Factors that predict response of patients with hepatitis C virus infection to boceprevir.
Gastroenterology 2012;143(3):608-18.e1-5.
2012: Thierry Poynard; Vlad Ratziu; Mona Munteanu; Yen Ngo; Jean Marie Castille; Olivier Deckmyn; Fabienne Drane; Chantal Housset; Françoise Imbert-Bismut
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
Journal of hepatology 2012;57(3):541-8.
2012: G Geri; F Imbert-Bismut; Thierry Poynard; D Saadoun; Damien Sène; B Terrier; Patrice Cacoub
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab.
Journal of viral hepatitis 2012;19(7):497-500.
2012: Olivier Lucidarme; Thierry Poynard; Julien Taieb; Genevieve Berger; Mehdi Cadi; Philippe Grenier; Ariel Beresniak
Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
European journal of radiology 2012;81(7):1413-9.
2012: Thierry Poynard; Vlad Ratziu; Jean Christophe Vaillant; Frederique Capron; Daniel Eyraud; Laurent Hannoun; Gilles Lenaour; Helmi M'Kada; Mona Munteanu; Yen Ngo; Frédéric Charlotte
Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012;10(6):657-63.e7.
2012: Johannes Vermehren; Stefan Zeuzem; Olga Zimmermann; Jörg Bojunga; Eva Herrmann; Wolf Peter Hofmann; Andreas Polta; Thierry Poynard; Christoph Sarrazin; Mireen Friedrich-Rust
Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(5):852-8.
2012: Marika Rudler; Maximilien Barret; Thierry Poynard; Dominique Thabut
Gastric mucormycosis: a rare cause of gastrointestinal bleeding in cirrhosis.
Clinics and research in hepatology and gastroenterology 2012;36(2):e32-3.
2012: Thierry Poynard; Vlad Ratziu; Carol Stanciu; Anca Trifan; Jean Christophe Vaillant; Julien Vergniol; Jean Pierre Zarski; Frédéric Charlotte; Victor de Ledinghen; Julie France; Gilles Le Naour; Mona Munteanu
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
Journal of hepatology 2012;56(3):541-8.
2012: Pierre-Yves Bochud; Marc Bourlière; Andreas Cerny; Guenter Dollenmaier; Jean-François Dufour; Tillman Gerlach; Nicolas Goossens; Meri Gorgiewski; Julien Guergnon; Markus H Heim; Hans Hirsch; Lorenz Kuske; Zoltan Kutalik; Raffaele Malinverni; Gladys Martinetti; Darius Moradpour; Beat Müllhaupt; Bertrand Nalpas; Francesco Negro; Etienne Patin; Stanislas Pol; Thierry Poynard; Stephan Regenass; Ioannis Theodorou; Laurent Abel; Stephanie Bibert
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.
Hepatology (Baltimore, Md.) 2012;55(2):384-94.
2012: Helmi M'Kada; Mona Munteanu; Yen Ngo; Hugo Perazzo; Charles Pierrot-Deseilligny; Thierry Poynard; Nittia Ramanujam; Vlad Ratziu; Yves Samson; Ina Schuppe-Koistinen; Patrick Tilleul; Zahir Amoura; Dominique Bonnefont-Rousselot; Philippe Boulogne; François Bricaire; Olivier Lyon Caen; Pierre Coriat; Olivier Deckmyn; Jean Yves Delattre; Vincent Nicolas Delpech; Bruno Fautrel; Serge Herson; Françoise Imbert-Bismut; David Khayat; Véronique Leblond
Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.
PloS one 2012;7(8):e42418.
2012: Johannes Vermehren; Stefan Zeuzem; Amina Carlebach; Nicole Forestier; Mireen Friedrich-Rust; Peter Gute; Eva Herrmann; Gaby Knecht; Thomas Lutz; Axel Mueller; Thierry Poynard; Christoph Sarrazin; Annika Vermehren; Wolf Peter Hofmann
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
BMC gastroenterology 2012;12():27.
2012: Thierry Poynard; Vlad Ratziu; Joan Tordjman; Pierre Bedossa; Robert Caïazzo; Robert Callafe; Frédéric Charlotte; Karine Clement; Bernard Demol; Emmanuel Diaz; Guillaume Lassailly; Philippe Mathurin; Mona Munteanu; François Pattou; Hugo Perazzo
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data.
PloS one 2012;7(3):e30325.
2011: Mona Munteanu; Vlad Ratziu; Thierry Poynard
The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis test.
The American journal of gastroenterology 2011;106(10):1853; author reply 1853-4.
2011: Benjamin Terrier; Fabrice CARRAT; Guillaume Geri; Philippe Halfon; Lionel Piroth; Stanislas Pol; Thierry Poynard; Jean-Claude Souberbielle; Patrice Cacoub
Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
Journal of hepatology 2011;55(4):756-61.
2011: Helmi M'Kada; Mona Munteanu; Yen Ngo; Hugo Perazzo; Thierry Poynard; Nittia Ramanujam; Vlad Ratziu; Ina Schuppe-Koistinen; Bernard Souberbielle; Dominique Bonnefont-Rousselot; Françoise Imbert-Bismut
What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI).
Regulatory toxicology and pharmacology : RTP 2011;60(3):290-5.
2011: Dominique Thabut; Géraldine Rousseau; Marika Rudler; Thierry Poynard
Recombinant activated factor VII in chronic liver diseases: should we be afraid of thromboembolic events?
Journal of hepatology 2011;55(2):483-5.
2011: Thierry Poynard; Dominique Thabut; Yves Benhamou; Pascal Lebray; Joseph Moussalli; Mona Munteanu; Yen Ngo; Hugo Perazzo; Vlad Ratziu
Prognostic value of liver fibrosis biomarkers: a meta-analysis.
Gastroenterology & hepatology 2011;7(7):445-54.
2011: Mona Munteanu; Vlad Ratziu; Thierry Poynard
FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted.
Journal of hepatology 2011;55(1):233; author reply 234-5.
2011: Jordi Bruix; Thierry Poynard; Massimo Colombo; Eugene R Schiff; Kelly Burak; Elizabeth J L Heathcote; Thomas Berg; Jorge-Luis Poo; Carlos Brandao Mello; Rainer Guenther; Claus Niederau; Ruben Terg; Pierre Bedossa; Navdeep Boparai; Louis H Griffel; Margaret Burroughs; Clifford A Brass; Janice K Albrecht
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.
Gastroenterology 2011;140(7):1990-9.
2011: Thierry Poynard; Dominique Thabut; Patricia Jabre; Mona Munteanu; Vlad Ratziu; Yves Benhamou; Olivier Deckmyn
Ranking hepatologists: which Hirsch's h-index to prevent the "e-crise de foi-e"?
Clinics and research in hepatology and gastroenterology 2011;35(5):375-86.
2011: Jean-Marc Costa; Dmytro Telehin; Mona Munteanu; Tetiana Kobryn; Yen Ngo; Vincent Thibault; Moussalli Joseph; Vlad Ratziu; Yves Benhamou; Volodymyr Koz'ko; Galyna Dubins'ka; Jean-Dominique Poveda; Thierry Poynard
HCV-GenoFibrotest: a combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C.
Clinics and research in hepatology and gastroenterology 2011;35(3):204-13.
2011: Thierry Poynard
First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy.
Journal of hepatology 2011;54(3):586-7.
2011: Daniel Eyraud; M Ben Menna; Jean-Christophe Vaillant; K Kitajima; Pascal Lebray; Alain Pavie; Thierry Poynard; Pierre Coriat; Laurent Hannoun
Perioperative management of combined heart-liver transplantation in patients with cirrhosis, renal insufficiency, or pulmonary hypertension.
Clinical transplantation 2011;25(2):228-34.
2011: Mona Munteanu; Bogdan Hermeziu; Francoise Imbert Bismut; Thierry Poynard
Performance of the FibroTest cannot be accurately estimated in nine paediatric patients with advanced fibrosis.
Scandinavian journal of infectious diseases 2011;43(2):159-60.
2011: Thierry Poynard; Mona Munteanu; Massimo Colombo; Jordi Bruix; Eugene R Schiff; Ruben Terg; Steven Flamm; Ricardo Moreno-Otero; Flair Jose Carrilho; Warren Schmidt; Thomas Berg; Thomas McGarrity; E Jenny Heathcote; Fernando Gonçales; Moises Diago; Antonio Craxi; Marcelo Silva; Navdeep Boparai; Louis Griffel; Margaret Burroughs; Clifford Brass; Janice Albrecht
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program.
Journal of hepatology 2011;54(2):227-35.
2011: Thierry Poynard; Mona Munteanu; Olivier Deckmyn; Yen Ngo; Fabienne Drane; Djamila Messous; Jean Marie Castille; Chantal Housset; Vlad Ratziu; Françoise Imbert-Bismut
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age.
BMC gastroenterology 2011;11():39.
2010: Patrick Marcellin; Jean-François Cadranel; Thierry Fontanges; Thierry Poynard; Stanislas Pol; Christian Trepo; Patrick Blin; Bruno Bregman; Nathalie Schmidely; Françoise Roudot-Thoraval; Jean-Pierre Zarski
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients.
European journal of gastroenterology & hepatology 2010;22(11):1290-6.
2010: Marika Rudler; Thierry Poynard; Dominique Thabut
Early use of TIPS for cirrhosis and variceal bleeding.
The New England journal of medicine 2010;363(14):1375; author reply 1376.
2010: Bertrand Nalpas; Roubila Lavialle-Meziani; Sabine Plancoulaine; Emmanuelle Jouanguy; Antoine Nalpas; Mona Munteanu; Frédéric Charlotte; Brigitte Ranque; Etienne Patin; Simon Heath; Hélène Fontaine; Anaïs Vallet-Pichard; Dominique Pontoire; Marc Bourlière; Jean-Laurent Casanova; Mark Lathrop; Christian Bréchot; Thierry Poynard; Fumihiko MATSUDA; Stanislas Pol; Laurent Abel
Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
Gut 2010;59(8):1120-6.
2010: Frédéric Charlotte; Gilles Le Naour; Carole Bernhardt; Thierry Poynard; Vlad Ratziu
A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C.
Human pathology 2010;41(8):1178-85.
2010: arnaud galbois; Marika Rudler; Julien Massard; Yvonne Fulla; Abdelhai Bennani; Dominique Bonnefont-Rousselot; Vincent Thibault; Stéphanie Reignier; Anne Bourrier; Thierry Poynard; Dominique Thabut
Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred.
Journal of hepatology 2010;52(6):839-45.
2010: I Baumgaertner; Vlad Ratziu; Jean-Christophe Vaillant; Laurent Hannoun; Thierry Poynard; Thierry André
[Hepatotoxicity of metastatic colorectal cancer chemotherapy: systematic review].
Bulletin du cancer 2010;97(5):559-69.
2010: Didier Lebrec; Dominique Thabut; Frédéric Oberti; Jean-Marc Perarnau; Bertrand Condat; Helene Barraud; Faouzi Saliba; Nicolas Carbonell; Philippe Renard; Marie-Jose Ramond; Richard Moreau; Thierry Poynard
Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis.
Gastroenterology 2010;138(5):1755-62.
2010: Philippe Bonnard; Roger Sombié; Francois-Xavier Lescure; Alain Bougouma; Jean-Baptiste Guiard-Schmid; Thierry Poynard; Paul Calès; Chantal Housset; Patrice Callard; Catherine Le Pendeven; Joseph Drabo; Fabrice CARRAT; Gilles Pialoux
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.
The American journal of tropical medicine and hygiene 2010;82(3):454-8.
2010: Mona Munteanu; Françoise Imbert-Bismut; Chantal Housset; Djamila Messous; Soraya Fellahi; Thierry Poynard
Evaluation of FibroTest inter-laboratory variations requires standardization on analytical systems and should not be mixed with underpowered histological validation.
Clinica chimica acta; international journal of clinical chemistry 2010;411(3-4):292-3.
2010: Vlad Ratziu; Frédéric Charlotte; Carole Bernhardt; Philippe Giral; Marine Halbron; Gilles Lenaour; Agnès Hartmann-Heurtier; Eric Bruckert; Thierry Poynard
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.
Hepatology (Baltimore, Md.) 2010;51(2):445-53.
2010: Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.
Gastroenterology 2010;138(2):513-21, 521.e1-6.
2010: Joseph Moussalli; Helene Delaquaize; Dominique Boubilley; Jean Pierre Lhomme; Jules Merleau Ponty; David Sabot; Anne Kerever; Marc Valleur; Thierry Poynard
Factors to improve the management of hepatitis C in drug users: an observational study in an addiction centre.
Gastroenterology research and practice 2010;2010():.
2010: Thierry Poynard; Dominique Thabut; Mona Munteanu; Vlad Ratziu; Yves Benhamou; Olivier Deckmyn
Hirsch index and truth survival in clinical research.
PloS one 2010;5(8):e12044.
2010: Thierry Poynard; Yen Ngo; Mona Munteanu; Dominique Thabut; Julien Massard; Joseph Moussalli; Anne Varaud; Yves Benhamou; Vlad Ratziu
Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
Antiviral therapy 2010;15(4):617-31.
2010: Thierry Poynard; Nezam H Afdhal
Perspectives on fibrosis progression in hepatitis C: an à la carte approach to risk factors and staging of fibrosis.
Antiviral therapy 2010;15(3):281-91.
2010: Thierry Poynard; Pascal Lebray; Patrick Ingiliz; Anne Varaut; Brigitte Varsat; Yen Ngo; Pascal Norha; Mona Munteanu; Fabienne Drane; Djamila Messous; Françoise Imbert Bismut; Jean Pierre Carrau; Julien Massard; Vlad Ratziu; Jean-Pierre Giordanella
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).
BMC gastroenterology 2010;10():40.
2010: B Hermeziu; Djamila Messous; Monique Fabre; Mona Munteanu; Christiane Baussan; Olivier Bernard; Thierry Poynard; Emmanuel Jacquemin
Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection.
Gastroentérologie clinique et biologique 2010;34(1):16-22.
2010: Mireen Friedrich-Rust; Cindy Müller; Anne Winckler; Susanne Kriener; Eva Herrmann; Julia Holtmeier; Thierry Poynard; Thomas J Vogl; Stefan Zeuzem; Renate Hammerstingl; Christoph Sarrazin
Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.
Journal of clinical gastroenterology 2010;44(1):58-65.
2009: Thierry Poynard; Eugene Shiff
Similarities and differences between REPEAT and EPIC3.
Annals of internal medicine 2009;151(10):754; author reply 754-5.
2009: Thierry Poynard; Julien Massard; M Rudler; A Varaud; Pascal Lebray; Joseph Moussalli; Mona Munteanu; Yen Ngo; Dominique Thabut; Yves Benhamou; Vlad Ratziu
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials.
Gastroentérologie clinique et biologique 2009;33(10-11):916-22.
2009: Vlad Ratziu; Laurence Martin; Larysa Fedchuk; Thierry Poynard
Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?
Biomarkers in medicine 2009;3(4):353-61.
2009: Mireen Friedrich-Rust; Katrin Wunder; Susanne Kriener; Fariba Sotoudeh; Swantje Richter; Joerg Bojunga; Eva Herrmann; Thierry Poynard; Christoph F Dietrich; Johannes Vermehren; Stefan Zeuzem; Christoph Sarrazin
Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.
Radiology 2009;252(2):595-604.
2009: Patrick Ingiliz; Kim Pav Chhay; Mona Munteanu; Pascal Lebray; Yen Ngo; Dominique Roulot; Yves Benhamou; Dominique Thabut; Vlad Ratziu; Thierry Poynard
Applicability and variability of liver stiffness measurements according to probe position.
World journal of gastroenterology : WJG 2009;15(27):3398-404.
2009: Stefan Zeuzem; Edward Gane; Yun-Fan Liaw; Seng G Lim; Adrian DiBisceglie; Maria Buti; Anuchit Chutaputti; Jens Rasenack; Jinlin Hou; Christopher B O'Brien; Tuan T Nguyen; Jidong Jia; Thierry Poynard; Bruce Belanger; Weibin Bao; Nikolai Naoumov
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.
Journal of hepatology 2009;51(1):11-20.
2009: Thierry Poynard; Yves Benhamou; Dominique Thabut; Vlad Ratziu
Liver biopsy: the best standard...when everything else fails.
Journal of hepatology 2009;50(6):1267-8.
2009: Thierry Poynard; Massimo Colombo; Jordi Bruix; Eugene R Schiff; Ruben Terg; Steven Flamm; Ricardo Moreno-Otero; Flair Jose Carrilho; Warren Schmidt; Thomas Berg; Thomas McGarrity; E Jenny Heathcote; Fernando Gonçales; Moises Diago; Antonio Craxi; Marcelo Silva; Pierre Bedossa; Pabak Mukhopadhyay; Louis Griffel; Margaret Burroughs; Clifford Brass; Janice Albrecht
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
Gastroenterology 2009;136(5):1618-28.e2.
2009: Thierry Poynard; Vlad Ratziu
Prolonged therapy for hepatitis C with low-dose peginterferon.
The New England journal of medicine 2009;360(11):1152; author reply 1152-3.
2009: Claire Vanlemmens; Vincent Di Martino; Chantal Milan; Michel Messner; Anne Minello; Christophe Duvoux; Thierry Poynard; Jean-Marc Perarnau; Marie-Anne Astrid Piquet; Georges-Philippe Pageaux; Sébastien Dharancy; Christine Silvain; Sophie Hillaire; Gérard Thiefin; Jean-Pierre Vinel; Patrick Hillon; Estelle Collin; Georges Mantion; Jean-Philippe Miguet
Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial.
Annals of internal medicine 2009;150(3):153-61.
2009: Patrick Ingiliz; Marc-Antoine Valantin; Claudine Duvivier; Fadia Medja; Stephanie Dominguez; Frédéric Charlotte; Roland Tubiana; Thierry Poynard; Christine Katlama; Anne Lombès; Yves Benhamou
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
Hepatology (Baltimore, Md.) 2009;49(2):436-42.
2009: Sylvie Naveau; Guillaume Gaudé; Amani Asnacios; Hélène Agostini; Annie Abella; Nadège Barri-Ova; Barbara Dauvois; Sophie Prévot; Yen Ngo; Mona Munteanu; Axel Balian; Micheline Njiké-Nakseu; Gabriel Perlemuter; Thierry Poynard
Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
Hepatology (Baltimore, Md.) 2009;49(1):97-105.
2009: Françoise Imbert-Bismut; Sylvie Naveau; Rachel Morra; Mona Munteanu; Vlad Ratziu; Annie Abella; Djamila Messous; Dominique Thabut; Yves Benhamou; Thierry Poynard
The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.
European journal of gastroenterology & hepatology 2009;21(1):18-27.
2008: Pascal Lebray; Shaïda Varnous; Frédéric Charlotte; Anne Varaut; Thierry Poynard; Vlad Ratziu
Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency.
Hepatology (Baltimore, Md.) 2008;48(6):2089.
2008: Thierry Poynard; Rachel Morra; Patrick Ingiliz; Françoise Imbert-Bismut; Dominique Thabut; Djamila Messous; Mona Munteanu; Julien Massard; Yves Benhamou; Vlad Ratziu
Assessment of liver fibrosis: noninvasive means.
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2008;14(4):163-73.
2008: Philippe Halfon; Mona Munteanu; Thierry Poynard
FibroTest-ActiTest as a non-invasive marker of liver fibrosis.
Gastroentérologie clinique et biologique 2008;32(6 Suppl 1):22-39.
2008: Mona Munteanu; Françoise Imbert-Bismut; Djamila Messous; Rachel Morra; Dominique Thabut; Pascal Lebray; Yves Benhamou; Vlad Ratziu; Thierry Poynard
Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.
Clinical biochemistry 2008;41(13):1113-4.
2008: Sophie Jacqueminet; Pascal Lebray; Rachel Morra; Mona Munteanu; Laure Devers; Djamila Messous; Maguy Bernard; Agnes Hartemann-Heurtier; Francoise Imbert-Bismut; Vlad Ratziu; Andre Grimaldi; Thierry Poynard
Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(7):828-31.
2008: Vlad Ratziu; Philippe Giral; Sophie Jacqueminet; Frédéric Charlotte; Agnès Hartemann-Heurtier; Lawrence Serfaty; Philippe Podevin; Jean-Marc Lacorte; Carole Bernhardt; Eric Bruckert; André Grimaldi; Thierry Poynard
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.
Gastroenterology 2008;135(1):100-10.
2008: Amani Asnacios; Laetitia Fartoux; Olivier Romano; Chloe Tesmoingt; Samy Louafi S; Touraj Mansoubakht; Pascal Artru; Thierry Poynard; Olivier Rosmorduc; Mohamed Hebbar; Julien Taieb
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study.
Cancer 2008;112(12):2733-9.
2008: Mona Munteanu; Vlad Ratziu; Rachel Morra; Djamila Messous; Francoise Imbert-Bismut; Thierry Poynard
Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
Journal of gastrointestinal and liver diseases : JGLD 2008;17(2):187-91.
2008: Mireen Friedrich-Rust; Constanze Koch; Axel Rentzsch; Christoph Sarrazin; Peter Schwarz; Eva Herrmann; Angelika Lindinger; Ulrike Sarrazin; Thierry Poynard; Hans-Joachim Schäfers; Stefan Zeuzem; Hashim Abdul-Khaliq
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
The Journal of thoracic and cardiovascular surgery 2008;135(3):560-7.
2008: Thierry Poynard; Patrick Ingiliz; Laure Elkrief; Mona Munteanu; Pascal Lebray; Rachel Morra; Djamila Messous; Francoise Imbert Bismut; Dominique Roulot; Yves Benhamou; Dominique Thabut; Vlad Ratziu
Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.
PloS one 2008;3(12):e3857.
2008: Patrick Ingiliz; Marc-Antoine Valantin; Vincent Thibault; Claudine Duvivier; Stephanie Dominguez; Christine Katlama; Thierry Poynard; Yves Benhamou
Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.
Antiviral therapy 2008;13(7):895-900.
2008: Thierry Poynard; Rachel Morra; Patrick Ingiliz; Françoise Imbert-Bismut; Dominique Thabut; Djamila Messous; Mona Munteanu; Julien Massard; Yves Benhamou; Vlad Ratziu
Biomarkers of liver fibrosis.
Advances in clinical chemistry 2008;46():131-60.
2008: Yen Ngo; Yves Benhamou; Vincent Thibault; Patrick Ingiliz; Mona Munteanu; Pascal Lebray; Dominique Thabut; Rachel Morra; Djamila Messous; Frédéric Charlotte; Françoise Imbert-Bismut; Dominique Bonnefont-Rousselot; Dominique Rousselot-Bonnefont; Joseph Moussalli; Vlad Ratziu; Thierry Poynard
An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.
PloS one 2008;3(7):e2573.
2008: Rachel Morra; Pascal Lebray; Patrick Ingiliz; Yen Ngo; Mona Munteanu; Vlad Ratziu; Thierry Poynard
FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2008;47(1):353-4; author reply 354-6.
2008: Georgia Malamut; Marianne Ziol; Felipe Suarez; Michel Beaugrand; Jean-François Viallard; Anne-Sophie Lascaux; Virginie Verkarre; Dominique Bechade; Thierry Poynard; Olivier Hermine; Christophe Cellier
Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
Journal of hepatology 2008;48(1):74-82.
2007: Dominique Thabut; Julien Massard; Alice Gangloff; Nicolas Carbonell; claire francoz; Eric Nguyen-Khac; Christian Duhamel; Didier Lebrec; Thierry Poynard; Richard Moreau
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.
Hepatology (Baltimore, Md.) 2007;46(6):1872-82.
2007: Dominique Thabut; Khalid A Tazi; Dominique Bonnefont-Rousselot; Maria Aller; Olivier Farges; Marie-Christine Guimont; Zéra Tellier; Cécile Guichard; Eric Ogier-Denis; Thierry Poynard; Richard Moreau; Didier Lebrec
High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.
Hepatology (Baltimore, Md.) 2007;46(6):1893-906.
2007: Maria Alessandra Rosenthal-Allieri; Albert Tran; Philippe Halfon; Françoise Imbert-Bismut; Mona Munteanu; Djamila Messous; Marie-Line Peritore; Thierry Poynard; Alain Bernard
Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
Gastroentérologie clinique et biologique 2007;31(10):815-21.
2007: Rachel Morra; Mona Munteanu; Pierre Bedossa; Delphine Dargere; Jean-Louis Janneau; Valérie Paradis; Vlad Ratziu; Frédéric Charlotte; Vincent Thibault; Françoise Imbert-Bismut; Thierry Poynard
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
Alimentary pharmacology & therapeutics 2007;26(6):847-58.
2007: Rachel Morra; Mona Munteanu; Françoise Imbert-Bismut; Djamila Messous; Vlad Ratziu; Thierry Poynard
FibroMAX: towards a new universal biomarker of liver disease?
Expert review of molecular diagnostics 2007;7(5):481-90.
2007: Thierry Poynard; Philippe Halfon; Laurent Castera; Mona Munteanu; Françoise Imbert-Bismut; Vlad Ratziu; Yves Benhamou; Marc Bourlière; Victor de Ledinghen
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.
Clinical chemistry 2007;53(9):1615-22.
2007: Jean-Pierre Zarski; Pierre Bedossa; Jean-Pierre Bronowicki; Michel Doffoel; Thierry Poynard
[Non invasive markers using for the assessment of fibrosis in hepatitis C].
Gastroentérologie clinique et biologique 2007;31(8-9 Pt 3):4S34-9.
2007: Dominique Thabut; Françoise Imbert-Bismut; Dominique Cazals-Hatem; Djamila Messous; Mona Muntenau; Dominique-Charles Valla; R Moreau; Thierry Poynard; Didier Lebrec
Relationship between the Fibrotest and portal hypertension in patients with liver disease.
Alimentary pharmacology & therapeutics 2007;26(3):359-68.
2007: Robert P Myers; Djamila Messous; Thierry Poynard; Françoise Imbert-Bismut
Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2007;21(5):289-94.
2007: M Simon-Rudler; Julien Massard; Brigitte Bernard-Chabert; Vincent Di Martino; Vlad Ratziu; Thierry Poynard; Dominique Thabut
Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
Alimentary pharmacology & therapeutics 2007;25(8):949-54.
2007: Samy Louafi; Valérie Boige; Michel Ducreux; Luminita Bonyhay; Touraj Mansourbakht; Thierry de Baere; Amani Asnacios; Laurent Hannoun; Thierry Poynard; Julien Taïeb
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study.
Cancer 2007;109(7):1384-90.
2007: Laetitia Fartoux; Françoise Degos; Christian Trépo; Odile Goria; Paul Calès; Albert Tran; Catherine Buffet; Thierry Poynard; Dominique Capron; Jean-Jacques Raabe; Dominique Roulot; Sylvie Naveau; jean didier grange; Raoul Poupon; Raoul Poupon; Lawrence Serfaty
Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(4):502-7.
2007: Thierry Poynard; P Halfon; Laurent Castera; Frédéric Charlotte; Brigitte Le Bail; Mona Munteanu; Djamila Messous; Vlad Ratziu; Yves Benhamou; Marc Bourlière; Victor de Ledinghen
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
Alimentary pharmacology & therapeutics 2007;25(6):733-9.
2007: Vlad Ratziu; Maria Vispo; Mohamed Tahiri; Luminita Bonyhay; Mercedes De Torres; Carole Bernhardt; Thierry Poynard; Pascal Lebray
[Can metabolic steatohepatitis be treated?].
Gastroentérologie clinique et biologique 2007;31(3):333-40.
2007: Sylvie Deuffic-Burban; Thierry Poynard; Mark S Sulkowski; John Wong
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.
Journal of viral hepatitis 2007;14(2):107-15.
2007: Vlad Ratziu; Philippe Giral; Mona Munteanu; Djamila Messous; Anne Mercadier; M Bernard; Rachel Morra; Françoise Imbert-Bismut; E Bruckert; Thierry Poynard
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia.
Alimentary pharmacology & therapeutics 2007;25(2):207-18.
2007: Thierry Poynard; Rachel Morra; Philippe Halfon; Laurent Castera; Vlad Ratziu; Françoise Imbert-Bismut; Sylvie Naveau; Dominique Thabut; Didier Lebrec; Fabien Zoulim; Marc Bourliere; Patrice Cacoub; Djamila Messous; Mona Munteanu; Victor de Ledinghen
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
BMC gastroenterology 2007;7():40.
2007: Hélène Prodanovic; Christophe Cracco; Julien Massard; Camille Barrault; Dominique Thabut; Alexandre Duguet; Annick Datry; Jean-Philippe Derenne; Thierry Poynard; Thomas Similowski
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series.
BMC gastroenterology 2007;7():2.
2006: Michal Abel; Damien Sène; Stanislas Pol; Marc Bourlière; Thierry Poynard; Frédéric Charlotte; Patrice Cacoub; Sophie Caillat-Zucman
Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2006;44(6):1607-16.
2006: Vlad Ratziu; Thierry Poynard
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.
Hepatology (Baltimore, Md.) 2006;44(4):802-5.
2006: John McHutchison; Thierry Poynard; Nezam H Afdhal
Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(10):1214-1220.
2006: Yen Ngo; Mona Munteanu; Djamila Messous; Frédéric Charlotte; Françoise Imbert-Bismut; Dominique Thabut; Pascal Lebray; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu; Thierry Poynard
A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
Clinical chemistry 2006;52(10):1887-96.
2006: Damien Sène; Nicolas Limal; Djamila Messous; Pascale Ghillani-Dalbin; Frédéric Charlotte; Jean-Marie Thiollière; Jean-Charles Piette; Françoise Imbert-Bismut; Philippe Halfon; Thierry Poynard; Patrice Cacoub
Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
Clinical biochemistry 2006;39(7):715-21.
2006: Dominique Thabut; Sophie Le Calvez; Vincent Thibault; Julien Massard; Mona Munteanu; Vincent Di Martino; Vlad Ratziu; Thierry Poynard
Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?
The American journal of gastroenterology 2006;101(6):1260-7.
2006: V Avettand-Fenoel; Dominique Thabut; Christine Katlama; Thierry Poynard; Vincent Thibault
Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.
Journal of clinical microbiology 2006;44(6):2250-3.
2006: Dominique Thabut; Sylvie Naveau; Frédéric Charlotte; Julien Massard; Vlad Ratziu; Françoise Imbert-Bismut; Dominique Cazals-Hatem; Annie Abella; Djamila Messous; Fabienne Beuzen; Mona Munteanu; Julien Taieb; Richard Moreau; Didier Lebrec; Thierry Poynard
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
Journal of hepatology 2006;44(6):1175-85.
2006: Philippe Halfon; Marc Bourlière; S Pol; Y Benhamou; Denis Ouzan; Michel Rotily; Hacène Khiri; Christophe Renou; Guillaume Pénaranda; David Saadoun; Vincent Thibault; J Serpaggi; M Varastet; Marie-Hélène Tainturier; Thierry Poynard; Patrice Cacoub
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.
Journal of viral hepatitis 2006;13(5):329-35.
2006: Fabien Zoulim; Thierry Poynard; Françoise Degos; Alain Slama; Abdelkader El Hasnaoui; Patrick Blin; F Mercier; Paul Deny; P Landais; Parviz Parvaz; Christian Trepo
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.
Journal of viral hepatitis 2006;13(4):278-88.
2006: Dominique Thabut; Jean-Baptiste Trabut; Julien Massard; Marika Rudler; Mona Muntenau; Djamila Messous; Thierry Poynard
Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(3):271-8.
2006: Olivier Lada; Yves Benhamou; Thierry Poynard; Vincent Thibault
Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants.
Journal of virology 2006;80(6):2968-75.
2006: C d'Arondel; Mona Munteanu; Joseph Moussalli; Vincent Thibault; Sylvie Naveau; A Simon; Djamila Messous; Rachel Morra; C Blot; Thierry Poynard
A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers.
Journal of viral hepatitis 2006;13(3):182-9.
2006: Valérie Boige; Julien Taïeb; Mohamed Hebbar; David Malka; Thierry Debaere; Laurent Hannoun; Emmanuelle Magherini; Dominique Mignard; Thierry Poynard; Michel Ducreux
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin level.
European journal of cancer (Oxford, England : 1990) 2006;42(4):456-9.
2006: Hassane Izzedine; Julien Massard; Thierry Poynard; Gilbert Deray
Lamivudine and HBV-associated nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(3):828-9.
2006: Michel Amouretti; Claude Le Pen; Anne-Françoise Gaudin; Gilles Bommelaer; Jacques Frexinos; Philippe Ruszniewski; Thierry Poynard; Frédérique Maurel; Gaël Priol; Abdelkader El Hasnaoui
Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL).
Gastroentérologie clinique et biologique 2006;30(2):241-6.
2006: Julien Taieb; Nathalie Chaput; Cédric Ménard; Lionel Apetoh; Evelyn Ullrich; Mathieu Bonmort; Marie Péquignot; Noelia Casares; Magali Terme; Caroline Flament; Paule Opolon; Yann Lecluse; Didier Métivier; Elena Tomasello; Eric Vivier; François Ghiringhelli; François Martin; David Klatzmann; Thierry Poynard; Thomas Tursz; Graça Raposo; Hideo Yagita; Bernard Ryffel; Guido Kroemer; Laurence Zitvogel
A novel dendritic cell subset involved in tumor immunosurveillance.
Nature medicine 2006;12(2):214-9.
2006: Thierry Poynard; Mona Munteanu; Yen Ngo; Mercedes Torres; Yves Benhamou; Dominique Thabut; Vlad Ratziu
Diagnostic value of FibroTest with normal serum aminotransferases.
Hepatology (Baltimore, Md.) 2006;43(2):374-5; author reply 375-6.
2006: Thierry Poynard; Vlad Ratziu; Frédéric Charlotte; Djamila Messous; Mona Munteanu; Françoise Imbert-Bismut; Julien Massard; Luminita Bonyhay; Mohamed Tahiri; Dominique Thabut; Jean-François Cadranel; Brigitte Le Bail; Victor de Ledinghen
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.
BMC gastroenterology 2006;6():34.
2006: Georges Férard; Annie Piton; Djamila Messous; Françoise Imbert-Bismut; Asmaa Frairi; Thierry Poynard; Jean-Marc Lessinger
Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(4):400-6.
2006: Vlad Ratziu; Julien Massard; Frédéric Charlotte; Djamila Messous; Françoise Imbert-Bismut; Luminita Bonyhay; Mohamed Tahiri; Mona Munteanu; Dominique Thabut; Jean-François Cadranel; Brigitte Le Bail; Victor de Ledinghen; Thierry Poynard
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
BMC gastroenterology 2006;6():6.
2006: Vlad Ratziu; Vincent Thibault; Yves Benhamou; Thierry Poynard
Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant.
Comparative hepatology 2006;5():1.
2006: Julien Massard; Vlad Ratziu; Dominique Thabut; Joseph Moussalli; Pascal Lebray; Yves Benhamou; Thierry Poynard
Natural history and predictors of disease severity in chronic hepatitis C.
Journal of hepatology 2006;44(1 Suppl):S19-24.
2006: Yves Benhamou; Vincent Thibault; Pamela Vig; Vincent Calvez; Anne-Geneviève Marcelin; Marie-Hélène Fievet; Graeme Currie; Chuy G Chang; Lu Biao; Shelly Xiong; Carol L Brosgart; Thierry Poynard
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.
Journal of hepatology 2006;44(1):62-7.
2005: Vlad Ratziu; Agnès Heurtier; Luminita Bonyhay; Thierry Poynard; Philippe Giral
Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link.
Alimentary pharmacology & therapeutics 2005;22 Suppl 2():56-60.
2005: Ting-Tsung Chang; Robert G Gish; Stephanos J Hadziyannis; Janusz Cianciara; Mario Rizzetto; Eugene R Schiff; Giuseppe Pastore; Bruce R Bacon; Thierry Poynard; Shobha Joshi; Kenneth S Klesczewski; Alexandra Thiry; Ronald E Rose; Richard J Colonno; Robert G Hindes
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.
Gastroenterology 2005;129(4):1198-209.
2005: Dorian McIlroy; Ioannis Théodorou; Vlad Ratziu; Dominique Vidaud; Philippe Pellet; Patrice Debré; Thierry Poynard
FAS promoter polymorphisms correlate with activity grade in hepatitis C patients.
European journal of gastroenterology & hepatology 2005;17(10):1081-8.
2005: Thierry Poynard; Fabien Zoulim; Vlad Ratziu; Françoise Degos; Françoise Imbert-Bismut; Paul Deny; Paul Landais; Abdelkader El Hasnaoui; Alain Slama; Patrick Blin; Vincent Thibault; Parviz Parvaz; Mona Munteanu; Christian Trepo
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
The American journal of gastroenterology 2005;100(9):1970-80.
2005: Ching-Lung Lai; Nancy Leung; Eng Kiong Teo; Myron Tong; Florence Wong; Hie-Won L Hann; Steven Han; Thierry Poynard; Maureen Myers; George C Chao; Deborah Lloyd; Nathaniel A Brown
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
Gastroenterology 2005;129(2):528-36.
2005: Annie Piton; Djamila Messous; Françoise Imbert-Bismut; J Bergès; Mona Munteanu; Thierry Poynard; Bernard Hainque
[Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test].
Annales de biologie clinique 2005;63(4):385-95.
2005: Vlad Ratziu; Frédéric Charlotte; Agnès Heurtier; Sophie Gombert; Philippe Giral; Eric Bruckert; André Grimaldi; Frédérique Capron; Thierry Poynard
Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
Gastroenterology 2005;128(7):1898-906.
2005: Françoise Imbert-Bismut; Djamila Messous; A Raoult; Thierry Poynard; Jean-Jacques Bertrand; P A Marie; V Louis; C Audy; J M Thouy; Bernard Hainque; Annie Piton
[Results transferability on RXL, ARX, X-Pand, BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest].
Annales de biologie clinique 2005;63(3):305-13.
2005: Thierry Poynard; Vlad Ratziu; Yves Benhamou; Dominique Thabut; Joseph Moussalli
Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?
Gastroenterology 2005;128(4):1146-8; author reply 1148.
2005: Sylvie Naveau; Bruno Raynard; Vlad Ratziu; Annie Abella; Françoise Imbert-Bismut; Djamila Messous; Fabienne Beuzen; Frédérique Capron; Dominique Thabut; Mona Munteanu; Jean-Claude Chaput; Thierry Poynard
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(2):167-74.
2005: Thierry Poynard; Vlad Ratziu; Ngo Kim; Sylvie Deuffic-Burban
Age and gender will survive to competing risks as fibrosis factors.
Gastroenterology 2005;128(2):519-20; author reply 520-1.
2005: Thierry Poynard; Françoise Imbert-Bismut; Mona Munteanu; Vlad Ratziu
Diagnosis and treatment of viral liver fibrosis.
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2005;11(1):1-19.
2005: Thierry Poynard; Vlad Ratziu; Sylvie Naveau; Dominique Thabut; Frédéric Charlotte; Djamila Messous; Dominique Capron; Annie Abella; Julien Massard; Yen Ngo; Mona Munteanu; Anne Mercadier; Michael Manns; Janice Albrecht
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis.
Comparative hepatology 2005;4():10.
2005: Georges Férard; Françoise Imbert-Bismut; Djamila Messous; Annie Piton; Shigeru Ueda; Thierry Poynard; Jean-Marc Lessinger
A reference material for traceability of aspartate aminotransferase (AST) results.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(5):549-53.
2005: Thierry Poynard; Françoise Imbert-Bismut; Mona Munteanu; Vlad Ratziu
FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?
Expert review of molecular diagnostics 2005;5(1):15-21.
2005: Vlad Ratziu; Thierry Poynard
NASH: a hidden and silent fibroser finally revealed?
Journal of hepatology 2005;42(1):12-4.
2004: Vlad Ratziu; Thierry Poynard
Long-term outcome improvement in patients with chronic hepatitis D treated with interferon alpha.
Nature clinical practice. Gastroenterology & hepatology 2004;1(2):76-7.
2004: Vincent Di Martino; Pascal Lebray; Robert P Myers; Emmanuelle Pannier; Valérie Paradis; Frédéric Charlotte; Joseph Moussalli; Dominique Thabut; Catherine Buffet; Thierry Poynard
Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.
Hepatology (Baltimore, Md.) 2004;40(6):1426-33.
2004: Thierry Poynard
Treatment of cirrhotic patients in the pegylated interferon era.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36 Suppl 3():S344-8.
2004: Dominique Thabut; Vincent Thibault; Brigitte Bernard-Chabert; Catherine Mouquet; Vincent Di Martino; Sophie Le Calvez; Pierre Opolon; Yves Benhamou; Marc-Olivier Bitker; Thierry Poynard
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.
European journal of gastroenterology & hepatology 2004;16(12):1367-73.
2004: Laurent Vallat; Yves Benhamou; Maya Gutierrez; Pascale Ghillani; Christel Hercher; Vincent Thibault; Frédéric Charlotte; Jean-Charles Piette; Thierry Poynard; Hélène Merle-Béral; Frédéric Davi; Patrice Cacoub
Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection.
Arthritis and rheumatism 2004;50(11):3668-78.
2004: Damien Sene; Pascale Ghillani-Dalbin; Vincent Thibault; Laurence Guis; Lucile Musset; Pierre Duhaut; Thierry Poynard; Jean-Charles Piette; Patrice Cacoub
Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
The Journal of rheumatology 2004;31(11):2199-206.
2004: Thierry Poynard
[The Fibrotest is an ethical choice because it is a cost-effective and anti-inflationistic test. Response to Jean Louis Payen and Jean Marie Combis].
Gastroentérologie clinique et biologique 2004;28(10 Pt 1):929-31.
2004: Thierry Poynard; Mona Munteanu; Françoise Imbert-Bismut; Frédéric Charlotte; Dominique Thabut; Sophie Le Calvez; Djamila Messous; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu
Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.
Clinical chemistry 2004;50(8):1344-55.
2004: Olivier Lada; Yves Benhamou; Annie Cahour; Christine Katlama; Thierry Poynard; Vincent Thibault
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Antiviral therapy 2004;9(3):353-63.
2004: Gilles Bommelaer; Thierry Poynard; Claude Le Pen; Anne-Françoise Gaudin; Frédérique Maurel; Gaël Priol; Michel Amouretti; Jacques Frexinos; Philippe Ruszniewski; Abdelkader El Hasnaoui
Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.
Gastroentérologie clinique et biologique 2004;28(6-7 Pt 1):554-61.
2004: Dominique Thabut; Vlad Ratziu; Jean-Baptiste Trabut; Thierry Poynard
Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone.
Gut 2004;53(6):913-4; author reply 914-5.
2004: Claude Le Pen; Philippe Ruszniewski; Anne-Françoise Gaudin; Michel Amouretti; Gilles Bommelaer; Jacques Frexinos; Thierry Poynard; Frédérique Maurel; Gaël Priol; C Bertin
The burden cost of French patients suffering from irritable bowel syndrome.
Scandinavian journal of gastroenterology 2004;39(4):336-43.
2004: Vlad Ratziu; Françoise Imbert-Bismut; Djamila Messous; Thierry Poynard
The elusiveness of "normal" ALT in fatty liver.
Hepatology (Baltimore, Md.) 2004;39(4):1172; author reply 1173.
2004: Françoise Imbert-Bismut; Djamila Messous; Vincent Thibault; Vincent Thibaut; Rob B Myers; Annie Piton; Dominique Thabut; Laure Devers; Bernard Hainque; Anne Mercadier; Thierry Poynard
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(3):323-33.
2004: Sophie Le Calvez; Dominique Thabut; Djamila Messous; Mona Munteanu; Vlad Ratziu; Françoise Imbert-Bismut; Thierry Poynard
The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2004;39(3):862-3; author reply 863.
2004: Sylvie Deuffic-Burban; John Wong; Alain-jacques Valleron; Dominique Costagliola; Jean-François Delfraissy; Thierry Poynard
Comparing the public health burden of chronic hepatitis C and HIV infection in France.
Journal of hepatology 2004;40(2):319-26.
2004: Heidi Hannon; Corinne Isnard Bagnis; Yves Benhamou; Hélène Beaufils; Mark Sullivan; Carol L Brosgart; Hassane Izzedine; Thierry Poynard; Gilbert Deray
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(2):386-90.
2004: Vlad Ratziu; Jean-Baptiste Trabut; Thierry Poynard
Fat, diabetes, and liver injury in chronic hepatitis C.
Current gastroenterology reports 2004;6(1):22-9.
2004: Nadia Alatrakchi; Vincent Di Martino; Vincent Thibault; Yves Benhamou; Christine Katlama; Thierry Poynard; Brigitte Autran
Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection.
AIDS (London, England) 2004;18(1):121-3.
2004: Robert P Myers; Yves Benhamou; Marie Bochet; Vincent Thibault; Delphine Mehri; Thierry Poynard
Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
AIDS (London, England) 2004;18(1):75-9.
2004: Thierry Poynard
Treatment of hepatitis C virus: the first decade.
Seminars in liver disease 2004;24 Suppl 2():19-24.
2003: Thierry Poynard; Man-Fung Yuen; Vlad Ratziu; Ching Lung Lai
Viral hepatitis C.
Lancet 2003;362(9401):2095-100.
2003: Ching-Lung Lai; Vlad Ratziu; Man-Fung Yuen; Thierry Poynard
Viral hepatitis B.
Lancet 2003;362(9401):2089-94.
2003: Julien Taïeb; Luminita Bonyhay; Lamia Golli; Michel Ducreux; Emmanuel Boleslawski; Jean-Marie Tigaud; Thierry de Baere; Touraj Mansourbakht; Marie Anna Delgado; Laurent Hannoun; Thierry Poynard; Valérie Boige
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.
Cancer 2003;98(12):2664-70.
2003: Vlad Ratziu; Mona Munteanu; Frédéric Charlotte; Luminita Bonyhay; Thierry Poynard
Fibrogenic impact of high serum glucose in chronic hepatitis C.
Journal of hepatology 2003;39(6):1049-55.
2003: Vlad Ratziu; Sophie Le Calvez; Luminita Bonyhay; Julien Taieb; Thierry Poynard
[Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?].
Gastroentérologie clinique et biologique 2003;27(10):869-75.
2003: Thierry Poynard
[Should we have the courage to say no to systematic liver biopsy?].
Gastroentérologie clinique et biologique 2003;27(8-9):844-6; author reply 846.
2003: Vlad Ratziu; Thierry Poynard
[Non-alcoholic steatosis: limits of current knowledge and lessons for hepatologists].
Gastroentérologie clinique et biologique 2003;27(8-9):715-7.
2003: Thierry Poynard; John McHutchison; Michael Manns; Robert P Myers; Janice Albrecht
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.
Hepatology (Baltimore, Md.) 2003;38(2):481-92.
2003: Robert P Myers; Marie-Hélène Tainturier; Vlad Ratziu; Annie Piton; Vincent Thibault; Françoise Imbert-Bismut; Djamila Messous; Frédéric Charlotte; Vincent Di Martino; Yves Benhamou; Thierry Poynard
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
Journal of hepatology 2003;39(2):222-30.
2003: Thierry Poynard; Vlad Ratziu; John McHutchison; Michael Manns; Zachary D Goodman; Stefan Zeuzem; Zobair M Younossi; Janice Albrecht
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.
Hepatology (Baltimore, Md.) 2003;38(1):75-85.
2003: Thierry Poynard; P Marcellin; A Bissery; Robert P Myers; Joseph Moussalli; Françoise Degos; Daniel Dhumeaux; G Riachi; J P Bronowicki; P Brissot; Catherine Buffet; Lawrence Serfaty; Sylvie Naveau; P Sogni; M Beaugrand; S Gayno; D Larrey; D Samuel; C Eugene; Stanislas Pol; Pierre Bedossa; V Daurat; P Chaumet-Riffaud
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial.
Journal of viral hepatitis 2003;10(3):197-204.
2003: Dominique Thabut; Marion Simon; Robert P Myers; Djamila Messous; Vincent Thibault; Françoise Imbert-Bismut; Thierry Poynard
Noninvasive prediction of fibrosis in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2003;37(5):1220-1; author reply 1221.
2003: Ronald L Koretz; Thierry Poynard
Truth is not determined by a majority vote.
Gastroenterology 2003;124(4):1153-5.
2003: Thierry Poynard; Dominique Thabut; Ariane Chryssostalis; Julien Taieb; Vlad Ratziu
Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?
Journal of hepatology 2003;38(4):518-20.
2003: Dominique Thabut; Vlad Ratziu; Brigitte Bernard-Chabert; Thierry Poynard; Yves Benhamou; Vincent Thibault
Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure.
Gut 2003;52(4):614.
2003: Robert P Myers; Yves Benhamou; Françoise Imbert-Bismut; Vincent Thibault; Marie Bochet; Frédéric Charlotte; Vlad Ratziu; François Bricaire; Christine Katlama; Thierry Poynard
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
AIDS (London, England) 2003;17(5):721-5.
2003: Robert P Myers; Vincent Thibault; Thierry Poynard
The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C.
Journal of viral hepatitis 2003;10(2):103-10.
2003: Thierry Poynard; Philippe Mathurin; Ching-Lung Lai; Dominique Guyader; Renée Poupon; Marie-Hélène Tainturier; Robert P Myers; Mona Muntenau; Vlad Ratziu; Michael Manns; Arndt Vogel; Frédérique Capron; Antonio Chedid; Pierre Bedossa
A comparison of fibrosis progression in chronic liver diseases.
Journal of hepatology 2003;38(3):257-65.
2003: Mercedes De Torres; Thierry Poynard
Risk factors for liver fibrosis progression in patients with chronic hepatitis C.
Annals of hepatology 2003;2(1):5-11.
2003: Yves Benhamou; Thierry Poynard
Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
Journal of hepatology 2003;39 Suppl 1():S194-9.
2003: Robert P Myers; Mercedes De Torres; Françoise Imbert-Bismut; Vlad Ratziu; Frédéric Charlotte; Thierry Poynard
Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index.
Digestive diseases and sciences 2003;48(1):146-53.
2003: Lamia Golli; Julien Taïeb; Emmanuel Boleslawski; Frédéric Charlotte; Jacques Taboury; Vincent Di Martino; Thierry Poynard; Laurent Hannoun
[Mucosa-associated lyphoid tissue hepatic lymphoma with low-grade malignancy associated with primary biliary cirrhosis].
Gastroentérologie clinique et biologique 2003;27(1):127-9.
2002: Magali Colombat; Frédéric Charlotte; Vlad Ratziu; Thierry Poynard
Portal lymphocytic infiltrate in alcoholic liver disease.
Human pathology 2002;33(12):1170-4.
2002: Julien Taïeb; Charlotte Delarche; Frédéric Ethuin; Saphia Selloum; Thierry Poynard; Marie-Anne Gougerot-Pocidalo; Sylvie Chollet-Martin
Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophils.
Journal of leukocyte biology 2002;72(6):1142-7.
2002: Vlad Ratziu; Maya Nourani; Thierry Poynard
Discussion on celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.
Gastroenterology 2002;123(6):2158-9; author reply 2159-60.
2002: Laurent Alric; Vincent Di Martino; Janick Selves; Patrice Cacoub; Frédéric Charlotte; Didier Reynaud; Jean-Charles Piette; Jean-Marie Péron; Jean-Pierre Vinel; Dominique Durand; Jacques Izopet; Thierry Poynard; Michel Duffaut; Lionel Rostaing
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection.
Gastroenterology 2002;123(5):1494-9.
2002: John G McHutchison; Michael Manns; Keyur Patel; Thierry Poynard; Karen L Lindsay; Christian Trepo; Jules L Dienstag; William M Lee; Carmen Mak; Jean-Jacques Garaud; Janice K Albrecht
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.
Gastroenterology 2002;123(4):1061-9.
2002: Pierre Pradat; Alfredo Alberti; Thierry Poynard; Juan Ignacio Esteban; Ola Weiland; Patrick Marcellin; Salvatore Badalamenti; Christian Trépo
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study.
Hepatology (Baltimore, Md.) 2002;36(4 Pt 1):973-7.
2002: Robert P Myers; Vlad Ratziu; Françoise Imbert-Bismut; Frédéric Charlotte; Thierry Poynard
Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
The American journal of gastroenterology 2002;97(9):2419-25.
2002: Pascal Lebray; Yves Benhamou; Stanislas Pol; Robert P Myers; Thierry Poynard; Vincent Di Martino
NNRTI-related or -unrelated hepatotoxicity?
Hepatology (Baltimore, Md.) 2002;36(2):512-3; author reply 513-4.
2002: Thierry Poynard; P Cacoub; Vlad Ratziu; Robert P Myers; M H Dezailles; Anne Mercadier; Pascale Ghillani; Frédéric Charlotte; J C Piette; Joseph Moussalli
Fatigue in patients with chronic hepatitis C.
Journal of viral hepatitis 2002;9(4):295-303.
2002: Thierry Poynard; Mona Munteanu; Vlad Ratziu; Yves Benhamou; Vincent Di Martino; Julien Taieb; Pierre Opolon
Truth survival in clinical research: an evidence-based requiem?
Annals of internal medicine 2002;136(12):888-95.
2002: Patrice Cacoub; Vlad Ratziu; Robert P Myers; Pascale Ghillani; Jean Charles Piette; Joseph Moussalli; Thierry Poynard
Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C.
Journal of hepatology 2002;36(6):812-8.
2002: Vlad Ratziu; Luminita Bonyhay; Vincent Di Martino; Frédéric Charlotte; Lucas Cavallaro; Marie-Hélène Sayegh-Tainturier; Philippe Giral; André Grimaldi; Pierre Opolon; Thierry Poynard
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.
Hepatology (Baltimore, Md.) 2002;35(6):1485-93.
2002: Vlad Ratziu; Marie-Hélène Sayegh-Tainturier; Maya Nourani; Thierry Poynard
[Pre-C mutations of the HBV].
Gastroentérologie clinique et biologique 2002;26(5):509-13.
2002: Thierry Poynard; John McHutchison; Michael Manns; Christian Trepo; Karen Lindsay; Zachary D Goodman; Mei-Hsiu Ling; Janice Albrecht
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.
Gastroenterology 2002;122(5):1303-13.
2002: Thierry Poynard
Uses of error.
Lancet 2002;359(9316):1514.
2002: Virginie Dangles; Vladimir Lazar; Pierre Validire; Sophie Richon; Mireille Wertheimer; V Laville; Jean-Louis Janneau; Michel Barrois; Christophe Bovin; Thierry Poynard; Guy Vallancien; Dominique Bellet
Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns.
British journal of cancer 2002;86(8):1283-9.
2002: Vincent Soriano; Mark S Sulkowski; Colm Bergin; Angelos Hatzakis; Patrice Cacoub; Christine Katlama; Antonietta Cargnel; Stefan Mauss; Douglas Dieterich; Santiago Moreno; Carlo Ferrari; Thierry Poynard; Jürgen Rockstroh
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.
AIDS (London, England) 2002;16(6):813-28.
2002: Robert P Myers; Corinne Regimbeau; Joseph Moussalli; Vlad Ratziu; Vincent Di Martino; Dominique Thabut; Brigitte Bernard; Yves Benhamou; Thierry Poynard
[What are the indications for treatment of acute hepatitis C?].
Gastroentérologie clinique et biologique 2002;26 Spec No 2():B188-93.
2002: Philippe Mathurin; Charles L Mendenhall; Robert L Carithers; Marie-José Ramond; Willis C Maddrey; Peter Garstide; Bernard Rueff; Sylvie Naveau; Jean-Claude Chaput; Thierry Poynard
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
Journal of hepatology 2002;36(4):480-7.
2002: Thierry Poynard; Françoise Imbert-Bismut; Vlad Ratziu; Sylvie Chevret; Claude Jardel; Joseph Moussalli; Djamila Messous; Françoise Degos
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial.
Journal of viral hepatitis 2002;9(2):128-33.
2002: Sylvie Deuffic-Burban; Thierry Poynard; Alain-jacques Valleron
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model.
Journal of viral hepatitis 2002;9(2):114-22.
2002: C Goulenok; Brigitte Bernard; Jean-François Cadranel; Dominique Thabut; Vincent Di Martino; Pierre Opolon; Thierry Poynard
Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
Alimentary pharmacology & therapeutics 2002;16(3):361-72.
2002: John G McHutchison; Thierry Poynard; Rafael Esteban-Mur; Gary L Davis; Zachary D Goodman; Joann Harvey; Mei-Hsiu Ling; Jean-Jacques Garaud; Janice K Albrecht; Keyur Patel; Jules L Dienstag; Timothy Morgan
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.
Hepatology (Baltimore, Md.) 2002;35(3):688-93.
2002: Julien Taïeb; Charlotte Delarche; Valérie Paradis; Philippe Mathurin; Alain Grenier; Bruno Crestani; Monique Dehoux; Dominique Thabut; Marie-Anne Gougerot-Pocidalo; Thierry Poynard; Sylvie Chollet-Martin
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis.
Journal of hepatology 2002;36(3):342-8.
2002: Chantal Halimi; Philippe Bonnard; Brigitte Bernard; Philippe Mathurin; Ali Mofredj; Vincent Di Martino; Renato Demontis; Edmond Henry-Biabaud; Patrick Fievet; Pierre Opolon; Thierry Poynard; Jean-François Cadranel
Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
European journal of gastroenterology & hepatology 2002;14(2):153-8.
2002: Robert P Myers; Thierry Poynard
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Cochrane database of systematic reviews (Online) 2002;(4):CD003617.
2002: Robert P Myers; Corinne Regimbeau; Thierry Thevenot; V Leroy; Philippe Mathurin; Pierre Opolon; Jean-Pierre Zarski; Thierry Poynard
Interferon for interferon naive patients with chronic hepatitis C.
Cochrane database of systematic reviews (Online) 2002;(2):CD000370.
2002: Thierry Poynard; Corinne Regimbeau; Robert P Myers; Thierry Thevenot; V Leroy; Philippe Mathurin; Pierre Opolon; Jean-Pierre Zarski
Interferon for acute hepatitis C.
Cochrane database of systematic reviews (Online) 2002;(1):CD000369.
2001: Dominique Thabut; Vincent Thibault; Yves Benhamou; Brigitte Bernard; Camille Aubron-Olivier; Thierry Poynard; Vincent Di Martino
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.
AIDS (London, England) 2001;15(18):2463-4.
2001: Gilles Bommelaer; Stanislas Bruley des Varannes; J F Fléjou; T Matysiak; Thierry Poynard; A Richard; Alain Slama; F Mégraud
[CagA status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study].
Gastroentérologie clinique et biologique 2001;25(12):1084-9.
2001: L Pieroni; L Khalil; Frédéric Charlotte; Thierry Poynard; Annie Piton; Bernard Hainque; Françoise Imbert-Bismut
Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration.
Clinical chemistry 2001;47(11):2059-61.
2001: Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Calvez; Marie-Hélène Fievet; P Vig; Craig S Gibbs; Carol L Brosgart; John Fry; Hamid Namini; Christine Katlama; Thierry Poynard
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
Lancet 2001;358(9283):718-23.
2001: Yves Benhamou; Vincent Di Martino; Marie Bochet; G Colombet; Vincent Thibault; A Liou; Christine Katlama; Thierry Poynard
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.
Hepatology (Baltimore, Md.) 2001;34(2):283-7.
2001: Thierry Poynard; Vlad Ratziu; Frédéric Charlotte; Zachary D Goodman; John McHutchison; Janice Albrecht
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.
Journal of hepatology 2001;34(5):730-9.
2001: Thierry Poynard; Corinne Regimbeau; Yves Benhamou
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.
Alimentary pharmacology & therapeutics 2001;15(3):355-61.
2001: T Thévenot; Corinne Regimbeau; Vlad Ratziu; V Leroy; Pierre Opolon; Thierry Poynard
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update.
Journal of viral hepatitis 2001;8(1):48-62.
2000: Catherine Mouquet; Brigitte Bernard; Thierry Poynard; Vincent Thibault; Pierre Opolon; Pierre Coriat; Marc-Olivier Bitker
Chronic hepatitis B treatment with lamivudine in kidney transplant patients.
Transplantation proceedings 2000;32(8):2762.
2000: Thierry Poynard; John McHutchison; Gary L Davis; Rafael Esteban-Mur; Zachary D Goodman; P Bedossa; Janice Albrecht
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2000;32(5):1131-7.
2000: Hervé Zylberberg; Yves Benhamou; J L Lagneaux; Alain Landau; Marie-Laure Chaix; Hélène Fontaine; Marie Bochet; Thierry Poynard; Christine Katlama; G Pialoux; Christian Bréchot; Stanislas Pol
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.
Gut 2000;47(5):694-7.
2000: John Wong; Thierry Poynard; Mei-Hsiu Ling; Janice K Albrecht; Stephen G Pauker
Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
The American journal of gastroenterology 2000;95(6):1524-30.
2000: Thierry Poynard; Vlad Ratziu; Pierre Bedossa
Appropriateness of liver biopsy.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2000;14(6):543-8.
2000: Vlad Ratziu; Philippe Giral; Frédéric Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; Pierre Opolon; Thierry Poynard
Liver fibrosis in overweight patients.
Gastroenterology 2000;118(6):1117-23.
2000: Thierry Poynard; Vlad Ratziu; Yves Benhamou; Corinne Regimbeau
[Treatment and prevention of hepatitis C].
La Revue du praticien 2000;50(10):1100-7.
2000: Thierry Poynard; Vlad Ratziu; Y Benhamou; Pierre Opolon; Patrice Cacoub; Pierre Bedossa
Natural history of HCV infection.
Baillière's best practice & research. Clinical gastroenterology 2000;14(2):211-28.
2000: Thierry Poynard; V Ratziu; Y Benmanov; Vincent Di Martino; Pierre Bedossa; P Opolon
Fibrosis in patients with chronic hepatitis C: detection and significance.
Seminars in liver disease 2000;20(1):47-55.
2000: Y Allory; Frédéric Charlotte; Y Benhamou; Pierre Opolon; Y Le Charpentier; Thierry Poynard
Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group.
Human pathology 2000;31(1):69-74.
2000: Thierry Poynard; John McHutchison; Zachary D Goodman; M H Ling; Janice Albrecht
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group.
Hepatology (Baltimore, Md.) 2000;31(1):211-8.
1999: Thierry Poynard; Joseph Moussalli; Vlad Ratziu; Corinne Regimbeau; Pierre Opolon
Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma.
Clinics in liver disease 1999;3(4):869-81.
1999: Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Di Martino; E Caumes; François Bricaire; Pierre Opolon; Christine Katlama; Thierry Poynard
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
Hepatology (Baltimore, Md.) 1999;30(5):1302-6.
1999: Patrice Cacoub; Thierry Poynard; Pascale Ghillani; Frédéric Charlotte; M Olivi; Jean-Charles Piette; P Opolon
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.
Arthritis and rheumatism 1999;42(10):2204-12.
1999: Yves Benhamou; Marie Bochet; Vincent Di Martino; Frédéric Charlotte; F Azria; A Coutellier; M Vidaud; François Bricaire; Pierre Opolon; Christine Katlama; Thierry Poynard
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.
Hepatology (Baltimore, Md.) 1999;30(4):1054-8.
1999: S Deuffic; Thierry Poynard; Alain-jacques Valleron
Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe.
Journal of viral hepatitis 1999;6(5):411-3.
1999: Thierry Poynard; V Daurat; Sylvie Chevret; Joseph Moussalli; Françoise Degos; F Bailly; E Borotto; Catherine Buffet; I Bartolomei-Portal; J P Richardet; G Riachi; Yvon Calmus; Christian Bréchot; M Vidaud; M Olivi; Pierre Bedossa; P C Riffaud; C Chastang
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 group.
Journal of viral hepatitis 1999;6(5):381-6.
1999: Vincent Thibault; Yves Benhamou; C Seguret; Marie Bochet; Christine Katlama; François Bricaire; Pierre Opolon; Thierry Poynard; Henri Agut
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus.
Journal of clinical microbiology 1999;37(9):3013-6.
1999: Françoise Imbert-Bismut; Frédéric Charlotte; B Turlin; L Khalil; Annie Piton; P Brissot; Y Le Charpentier; Jacques Delattre; Pierre Opolon; Y Deugnier; Thierry Poynard
Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring.
Journal of clinical pathology 1999;52(6):430-4.
1999: Thierry Poynard; Sylvie Naveau; Michel Doffoel; Karim Boudjema; Claire Vanlemmens; Georges Mantion; Michel Messner; Bernard Launois; Didier Samuel; Daniel Cherqui; Georges-Philippe Pageaux; Pierre-Henri Bernard; Yvon Calmus; Jean-Pierre Zarski; Jean-Philippe Miguet; Jean-Claude Chaput
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group.
Journal of hepatology 1999;30(6):1130-7.
1999: Brigitte Bernard; Jean-Didier Grangé; E N Khac; Xavier Amiot; Pierre Opolon; Thierry Poynard
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
Hepatology (Baltimore, Md.) 1999;29(6):1655-61.
1999: S Deuffic; Laurent Buffat; Thierry Poynard; Alain-jacques Valleron
Modeling the hepatitis C virus epidemic in France.
Hepatology (Baltimore, Md.) 1999;29(5):1596-601.
1999: P Calès; D Castaing; Jean-Didier Grangé; D Lebrec; O Lemoine; Thierry Poynard; Christine Silvain; P Sogni; JP Vinel; C Vons; Olivier Nouel; N Bourgeois; Brigitte Bernard; A Hadengue
[Treatment of portal hypertension].
Gastroentérologie clinique et biologique 1999;23(3):353-4.
1999: R Sobesky; Philippe Mathurin; Frédéric Charlotte; Joseph Moussalli; M Olivi; M Vidaud; Vlad Ratziu; Pierre Opolon; Thierry Poynard
Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.
Gastroenterology 1999;116(2):378-86.
1999: Thierry Poynard; J Moussali; Vlad Ratziu; Corinne Regimbeau; Pierre Opolon
Effects of interferon therapy in "non responder" patients with chronic hepatitis C.
Journal of hepatology 1999;31 Suppl 1():178-83.
1999: Thierry Poynard
[Role and limits of self-medication in the therapeutic strategy of gastroesophageal reflux in adults].
Gastroentérologie clinique et biologique 1999;23(1 Pt 2):S176-9.
1999: Philippe Mathurin; Catherine Mouquet; Thierry Poynard; C Sylla; Hadjira Benalia; C Fretz; Vincent Thibault; Jean-François Cadranel; Brigitte Bernard; Pierre Opolon; Pierre Coriat; Marc-Olivier Bitker
Impact of hepatitis B and C virus on kidney transplantation outcome.
Hepatology (Baltimore, Md.) 1999;29(1):257-63.
1998: Philippe Mathurin; Julien Taïeb; Thierry Poynard
[Corticosteroid therapy in acute severe alcoholic hepatitis: the end of a controversy?].
Gastroentérologie clinique et biologique 1998;22(12):991-5.
1998: Thierry Poynard; Joseph Moussalli; Vlad Ratziu; Thierry Thevenot; Corinne Regimbeau; Pierre Opolon; yves horsmans; R Brenard; M Closon; J Fevery; ML Hautekeete
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie.
Acta gastro-enterologica Belgica 1998;61(4):431-7.
1998: J Desramé; Philippe Mathurin; R Rozov; JM Sabaté; Thierry Poynard; Pierre Opolon; J Denis
[Isolated ascites revealing a hypothyroidism. Study of 2 cases].
Gastroentérologie clinique et biologique 1998;22(8-9):732-5.
1998: Brigitte Bernard; Jean-Didier Grangé; E N Khac; Xavier Amiot; Pierre Opolon; Thierry Poynard
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis.
Digestion 1998;59 Suppl 2():54-7.
1998: Patrice Cacoub; Lucile Musset; Pierre Hausfater; Pascale Ghillani; F L Fabiani; Frédéric Charlotte; E Angevin; P Opolon; Thierry Poynard; Jean-Charles Piette; B Autran
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.
Clinical and experimental immunology 1998;113(1):48-54.
1998: Annie Piton; Thierry Poynard; Françoise Imbert-Bismut; L Khalil; Jacques Delattre; E Pelissier; N Sansonetti; Pierre Opolon
Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.
Hepatology (Baltimore, Md.) 1998;27(5):1213-9.
1998: Philippe Mathurin; Nathalie Ganne-Carrié; Thierry Poynard; Jean-Claude Trinchet
[Pro-inflammatory cytokines in the pathogenesis of alcoholic hepatitis].
Gastroentérologie clinique et biologique 1998;22(3):311-9.
1998: Philippe Mathurin; Joseph Moussalli; Jean-François Cadranel; Vincent Thibault; Frédéric Charlotte; Patrice Dumouchel; Alain Cazier; Jean-Marie Huraux; Bruno Devergie; M Vidaud; Pierre Opolon; Thierry Poynard
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
Hepatology (Baltimore, Md.) 1998;27(3):868-72.
1998: Thierry Poynard; B Vernisse; H Agostini
Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux.
Alimentary pharmacology & therapeutics 1998;12(2):159-65.
1998: Philippe Mathurin; O Rixe; Nicolas Carbonell; B Bernard; Philippe Cluzel; M F Bellin; D Khayat; P Opolon; Thierry Poynard
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?
Alimentary pharmacology & therapeutics 1998;12(2):111-26.
1998: S Deuffic; Thierry Poynard; Laurent Buffat; Alain-jacques Valleron
Trends in primary liver cancer.
Lancet 1998;351(9097):214-5.
1997: Patrice Cacoub; Lucile Musset; Zahir Amoura; P Guilani; H Chabre; Françoise Lunel; Thierry Poynard; P Opolon; Jean-Charles Piette
Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group.
The Journal of rheumatology 1997;24(11):2139-44.
1997: V Paradis; M Kollinger; M Fabre; A Holstege; Thierry Poynard; P Bedossa
In situ detection of lipid peroxidation by-products in chronic liver diseases.
Hepatology (Baltimore, Md.) 1997;26(1):135-42.
1997: V Paradis; P Mathurin; M Kollinger; Françoise Imbert-Bismut; Frédéric Charlotte; Annie Piton; Pierre Opolon; A Holstege; Thierry Poynard; P Bedossa
In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.
Journal of clinical pathology 1997;50(5):401-6.
1997: Thierry Poynard; Pierre Bedossa
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups.
Journal of viral hepatitis 1997;4(3):199-208.
1997: Anne Auperin; Jean-Pierre Pignon; Thierry Poynard
Review article: critical review of meta-analyses of randomized clinical trials in hepatogastroenterology.
Alimentary pharmacology & therapeutics 1997;11(2):215-25.
1997: Thierry Poynard; P Bedossa; P Opolon
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
Lancet 1997;349(9055):825-32.
1997: Brigitte Bernard; D Lebrec; Philippe Mathurin; Pierre Opolon; Thierry Poynard
Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.
Journal of hepatology 1997;26(2):312-24.
1997: Thierry Poynard; Y Ottignon; C Pauphilet; H Agostini
[Evaluation by a randomized trial of the usefulness of endoscopy after treatment of a flare-up of non-severe esophagitis].
Gastroentérologie clinique et biologique 1997;21(6-7):497-502.
1997: Thierry Poynard
[Should hepatitis C be treated? What are indications of treatment in acute hepatitis C?].
Gastroentérologie clinique et biologique 1997;21(1 Pt 2):S66-9.
1997: G Tordjman; Brigitte Bernard; J P Chigot; Thierry Poynard; Pierre Opolon
[Recurrent lower digestive hemorrhage in young adults: a surgical indication].
Gastroentérologie clinique et biologique 1997;21(3):217-8.
1997: Brigitte Bernard; D Lebrec; Philippe Mathurin; Pierre Opolon; Thierry Poynard
Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.
Hepatology (Baltimore, Md.) 1997;25(1):63-70.
1996: Valérie Paradis; Philippe Mathurin; A Laurent; Frédéric Charlotte; M Vidaud; Thierry Poynard; C Hoang; Pierre Opolon; Pierre Bedossa
Histological features predictive of liver fibrosis in chronic hepatitis C infection.
Journal of clinical pathology 1996;49(12):998-1004.
1996: Thierry Poynard; V Leroy; Philippe Mathurin; M Cohard; Pierre Opolon; Jean-Pierre Zarski
Treatment of chronic hepatitis C by interferon for longer duration than six months.
Digestive diseases and sciences 1996;41(12 Suppl):99S-102S.
1996: Philippe Mathurin; Jean-François Cadranel; Dalila Bouraya; Jean-Ariel Bronstein; G Collot; Bruno Devergie; Thierry Poynard; Pierre Opolon
Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four cases.
European journal of gastroenterology & hepatology 1996;8(11):1129-31.
1996: Yves Benhamou; Christine Katlama; F Lunel; A Coutellier; E Dohin; N Hamm; Roland Tubiana; S Herson; Thierry Poynard; Pierre Opolon
Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.
Annals of internal medicine 1996;125(9):705-12.
1996: Thierry Poynard; V Leroy; M Cohard; Thierry Thevenot; Philippe Mathurin; Pierre Opolon; Jean-Pierre Zarski
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
Hepatology (Baltimore, Md.) 1996;24(4):778-89.
1996: Pierre Bedossa; Thierry Poynard
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.
Hepatology (Baltimore, Md.) 1996;24(2):289-93.
1996: Valérie Paradis; A Laurent; Philippe Mathurin; Thierry Poynard; D Vidaud; M Vidaud; Pierre Bedossa
Role of liver extracellular matrix in transcriptional and post-transcriptional regulation of apolipoprotein A-I by hepatocytes.
Cellular and molecular biology (Noisy-le-Grand, France) 1996;42(4):525-34.
1996: Valérie Paradis; Philippe Mathurin; Vlad Ratziu; Thierry Poynard; Pierre Bedossa
Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix.
Hepatology (Baltimore, Md.) 1996;23(5):1232-8.
1996: Philippe Mathurin; D Vidaud; M Vidaud; Pierre Bedossa; Valérie Paradis; Vlad Ratziu; Jean-Claude Chaput; Thierry Poynard
Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease.
Hepatology (Baltimore, Md.) 1996;23(1):44-51.
1995: Thierry Poynard; M Lemaire; H Agostini
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
European journal of gastroenterology & hepatology 1995;7(7):661-5.
1995: Thierry Poynard; Pierre Bedossa; M Chevallier; P Mathurin; C Lemonnier; C Trepo; P Couzigou; J L Payen; M Sajus; J M Costa
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
The New England journal of medicine 1995;332(22):1457-62.
1995: Yves Benhamou; E Dohin; F Lunel-Fabiani; Thierry Poynard; J M Huraux; Christine Katlama; Pierre Opolon; M Gentilini
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
Lancet 1995;345(8946):396-7.
1995: Thierry Poynard; I Lonjon; Philippe Mathurin; Annie Abella; D Musset; Pierre Bedossa; A Aubert; Sylvie Naveau; Jean-Claude Chaput
Prevalence of cholelithiasis according to alcoholic liver disease: a possible role of apolipoproteins AI and AII.
Alcoholism, clinical and experimental research 1995;19(1):75-80.
1995: Thierry Poynard; Pierre Bedossa; Philippe Mathurin; Vlad Ratziu; Valérie Paradis
Apolipoprotein A1 and hepatic fibrosis.
Journal of hepatology 1995;22(2 Suppl):107-10.
1994: M Cohard; Thierry Poynard; Philippe Mathurin; Jean-Pierre Zarski
Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.
Hepatology (Baltimore, Md.) 1994;20(6):1390-8.
1994: Sylvie Naveau; Thierry Poynard; C Benattar; Pierre Bedossa; Jean-Claude Chaput
Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest.
Digestive diseases and sciences 1994;39(11):2426-32.
1994: Thierry Poynard; Sylvie Naveau; B Mory; Jean-Claude Chaput
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.
Alimentary pharmacology & therapeutics 1994;8(5):499-510.
1994: Thierry Poynard; P Barthelemy; S Fratte; Karim Boudjema; Michel Doffoel; Claire Vanlemmens; Jean-Philippe Miguet; G Mantion; M Messner; B Launois
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls.
Lancet 1994;344(8921):502-7.
1994: Axel Holstege; Pierre Bedossa; Thierry Poynard; M Kollinger; J C Chaput; K Houglum; M Chojkier
Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis.
Hepatology (Baltimore, Md.) 1994;19(2):367-74.
1993: Thierry Poynard
Relapse rate of patients after healing of oesophagitis--a prospective study of alginate as self-care treatment for 6 months. French Co-operative Study Group.
Alimentary pharmacology & therapeutics 1993;7(4):385-92.
1992: Sylvie Naveau; L Barritault; O Zourabichvili; C Champagne; G Prieur; A Limoge; Thierry Poynard; Jean-Claude Chaput
[Analgesic effect of transcutaneous cranial electrostimulation in patients treated by Nd:YAG laser for cancer of the rectum. A double-blind randomized trial].
Gastroentérologie clinique et biologique 1992;16(1):8-11.
1991: Sylvie Naveau; Pierre Bedossa; Thierry Poynard; B Mory; Jean-Claude Chaput
Portal hypertensive colopathy. A new entity.
Digestive diseases and sciences 1991;36(12):1774-81.
1991: Thierry Poynard; A Aubert; Y Lazizi; Pierre Bedossa; B Hamelin; B Terris; Sylvie Naveau; P Dubreuil; J Pillot; Jean-Claude Chaput
Independent risk factors for hepatocellular carcinoma in French drinkers.
Hepatology (Baltimore, Md.) 1991;13(5):896-901.
1991: Thierry Poynard; A Aubert; Pierre Bedossa; Annie Abella; Sylvie Naveau; F Paraf; Jean-Claude Chaput
A simple biological index for detection of alcoholic liver disease in drinkers.
Gastroenterology 1991;100(5 Pt 1):1397-402.
1991: Sylvie Naveau; C Perrier; B Mory; Thierry Poynard; Jean-Claude Chaput
[Endoscopic hemostasis for hemorrhagic gastroduodenal ulcer. Meta-analysis of randomized clinical trials].
Gastroentérologie clinique et biologique 1991;15(8-9):580-7.
1991: Thierry Poynard; Pierre Bedossa; P Mathurin; Sylvie Naveau; J F Delfraissy; G Lemaigre; Jean-Claude Chaput
Efficacy of long term recombinant interferon-alfa in patients with chronic hepatitis C. A clinical, biological, histological and immunohistological study.
Gastroentérologie clinique et biologique 1991;15(8-9):615-9.
1990: Thierry Poynard; Pierre Bedossa; Philippe Jais; Annie Abella; Sylvie Naveau; A Aubert; G Lemaigre; Jean-Claude Chaput
Serum apolipoprotein A-I in alcoholic patients with chronic calcifying pancreatitis.
Pancreas 1990;5(5):519-23.
1990: Sylvie Naveau; A Aubert; Thierry Poynard; Jean-Claude Chaput
Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation.
Digestive diseases and sciences 1990;35(7):821-6.
1990: S Pol; Thierry Poynard; Pierre Bedossa; Sylvie Naveau; A Aubert; Jean-Claude Chaput
Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis.
Alcoholism, clinical and experimental research 1990;14(2):250-4.
1990: Pierre Bedossa; Thierry Poynard; J Bacci; Sylvie Naveau; G Lemaigre; Jean-Claude Chaput; E Martin
Expression of histocompatibility antigens and characterization of the lymphocyte infiltrate in hyperplastic polyps of the large bowel.
Human pathology 1990;21(3):319-24.
1990: Sylvie Naveau; A Chiesa; Thierry Poynard; Jean-Claude Chaput
Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcome.
Digestive diseases and sciences 1990;35(3):294-301.
1990: Thierry Poynard
[Modesty, uncertainty and pragmatism].
Gastroentérologie clinique et biologique 1990;14(6-7):600.
1990: Thierry Poynard; C Klepping; J C Audigier; C Barthelemy; A Bel; J Delmont; J Fournet; P Gaucher; M Rachail
Randomized double-blind clinical trial of aluminum phosphate versus ranitidine in the acute treatment of duodenal ulcer.
Digestion 1990;47(2):105-10.
1990: Sylvie Naveau; B Mory; Thierry Poynard; Jean-Claude Chaput
[Randomized therapeutic trials in intestinal functional disorders].
Gastroentérologie clinique et biologique 1990;14(5 ( Pt 2)):65C-73C.
1990: B Mory; Thierry Poynard; Sylvie Naveau; Jean-Claude Chaput
[Epidemiology and methodology of randomized therapeutic trials in patients with intestinal functional disorders].
Gastroentérologie clinique et biologique 1990;14(5 ( Pt 2)):58C-64C.
1990: Thierry Poynard; M Lemann; Stéfan Darmoni
[What to expect from expert systems for the diagnosis of functional bowel disorders].
Gastroentérologie clinique et biologique 1990;14(5 ( Pt 2)):45C-48C.
1990: Thierry Poynard
[Short-term severity factors of digestive hemorrhage caused by portal hypertension in patients with cirrhosis].
Gastroentérologie clinique et biologique 1990;14(1 ( Pt 2)):21B-24B.
1990: D Pateron; Sylvie Naveau; Francois Gilles BRIVET; Pierre Bedossa; Thierry Poynard; Jean-Claude Chaput
[Acute tuberculous pancreatitis in a patient with acquired immunodeficiency syndrome].
Gastroentérologie clinique et biologique 1990;14(1):80-3.
1989: Pierre Bedossa; Thierry Poynard; Annie Abella; A Aubert; J P Pignon; Sylvie Naveau; R Leluc; G Lemaigre; E D Martin; Jean-Claude Chaput
Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients.
Alcoholism, clinical and experimental research 1989;13(6):829-33.
1989: Thierry Poynard; Pierre Bedossa; Sylvie Naveau; G Lemaigre; E D Martin; Jean-Claude Chaput
Perisinusoidal cells (Ito-cells) enlargement in a family with myotonic dystrophy.
Liver 1989;9(5):276-8.
1989: F Paraf; Sylvie Naveau; O Zourabichvili; Thierry Poynard; Jean-Claude Chaput
Endoscopic laser therapy for duodenal villous adenoma.
Digestive diseases and sciences 1989;34(9):1466-7.
1989: Pierre Bedossa; Thierry Poynard; Annie Abella; F Paraf; G Lemaigre; E Martin
Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries.
Archives of pathology & laboratory medicine 1989;113(7):777-80.
1989: Thierry Poynard
[The liver under top protection?].
Gastroentérologie clinique et biologique 1989;13(6-7):542-3.
1989: Sylvie Naveau; P Bedossa; L Mallet; L Turner; Thierry Poynard; T Andréani; Jean-Claude Chaput
Successful ablation of a large fibrovascular polyp of the esophagus by endoscopic Nd:YAG laser therapy.
Gastrointestinal endoscopy 1989;35(3):254-6.
1989: Sylvie Naveau; Thierry Poynard; O Zourabichvili; A Poitrine; Jean-Claude Chaput
A randomized study of a coaxial fiber versus a naked fiber for endoscopic Nd:YAG laser therapy of esophageal and rectal tumors.
Gastrointestinal endoscopy 1989;35(3):201-6.
1989: Thierry Poynard; J P Pignon; B Mory; Sylvie Naveau; Jean-Claude Chaput
Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection.
Gastroentérologie clinique et biologique 1989;13(1 Pt 1):112B-115B.
1988: Thierry Poynard; A Aubert; Sylvie Naveau; M Lemman; Jean-Claude Chaput
[Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients].
Gastroentérologie clinique et biologique 1988;12(12):899-905.
1988: Thierry Poynard; J M Tournade; B Alberola; M Pappo
[Semiology of gastroduodenal ulcer proved by endoscopy: epidemiological analysis of 1,800 cases].
Gastroentérologie clinique et biologique 1988;12(8-9):596-603.
1988: C Geffriaud; Thierry Poynard; J F Delfraissy; Pierre Bedossa; Sylvie Naveau; P Bourée; P Dubreuil; Jean-Claude Chaput
[Hepatic involvement in HIV 1 virus infection].
Gastroentérologie clinique et biologique 1988;12(5):465-72.
1988: Pierre Bedossa; Thierry Poynard; Sylvie Naveau; E D Martin; H Agostini; Jean-Claude Chaput
Observer variation in assessment of liver biopsies of alcoholic patients.
Alcoholism, clinical and experimental research 1988;12(1):173-8.
1987: J P Pignon; Thierry Poynard; Sylvie Naveau; G Sebag; Jean-Claude Chaput
[Treatment of gastroesophageal reflux: analysis of randomized double-blind trials].
Gastroentérologie clinique et biologique 1987;11(10):668-80.
1987: Sylvie Naveau; O Zourabichvili; A Poitrine; C Houdayer; Thierry Poynard; Jean-Claude Chaput
[Palliative treatment of cancers of the esophagus and cardia with neodymium YAG laser: short-term results and multidimensional analysis of factors related to functional improvement and tumor destruction].
Gastroentérologie clinique et biologique 1987;11(5):364-70.
1986: Sylvie Naveau; Thierry Poynard; O Zourabichvili; A Poitrine; Jean-Claude Chaput
Gastric phytobezoar destruction by Nd:YAG laser therapy.
Gastrointestinal endoscopy 1986;32(6):430-1.
1986: Thierry Poynard; Annie Abella; J P Pignon; Sylvie Naveau; R Leluc; Jean-Claude Chaput
Apolipoprotein AI and alcoholic liver disease.
Hepatology (Baltimore, Md.) 1986;6(6):1391-5.
1986: Sylvie Naveau; D Roulot; O Zourabichvili; A Poitrine; Thierry Poynard; Jean-Claude Chaput
[Palliative treatment of adenocarcinoma of the rectum by Nd-YAG laser. Immediate and long-term results. Study of factors related to the initial destruction of the tumor].
Gastroentérologie clinique et biologique 1986;10(10):651-5.
1986: J P Pignon; Thierry Poynard; Sylvie Naveau; P Marteau; O Zourabichvili; Jean-Claude Chaput
[Multidimensional analysis by Cox's model of the survival of patients with alcoholic cirrhosis].
Gastroentérologie clinique et biologique 1986;10(6-7):461-7.
1985: Sylvie Naveau; Thierry Poynard; Annie Abella; J P Pignon; A Poitrine; H Agostini; O Zourabichvili; Jean-Claude Chaput
Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients.
Hepatology (Baltimore, Md.) 1985;5(5):819-23.
1984: Thierry Poynard; O Zourabichvili; G Hilpert; Sylvie Naveau; A Poitrine; C Benatar; Jean-Claude Chaput
Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients.
Hepatology (Baltimore, Md.) 1984;4(2):324-7.
1983: Thierry Poynard; Sylvie Naveau; A Poitrine; P Lebourgeois; G Hilpert; Jean-Claude Chaput
Recurrent bleeding and propranolol?
Digestive diseases and sciences 1983;28(7):667.
1983: A Poitrine; Thierry Poynard; Sylvie Naveau; G Hilpert; Jean-Claude Chaput
[A new fatal case of hepatitis caused by clometacin].
Gastroentérologie clinique et biologique 1983;7(1):99.